1512MO Perioperative camrelizumab (C) combined with rivoceranib (R) and chemotherapy (chemo) versus chemo for locally advanced resectable gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The first interim analysis of a randomized, phase III trial (DRAGON IV)

Changhui Li, Yingjie Zheng, Zhen Shi, Li-Kuei Yang, Bo Zhang, Zhiqiang Wang, Huijiao Chen, Xiaohua Wang, Peng Zhao, Jiahong Dong, Chao Lian, Qingjun Zhao, Zheng Zheng, Andrew Zhang, Shan Xu, K. Wang, Fei Yuan, Yuan Tian, Kai Yin, Zheng Zhu